Citi lowered the firm’s price target on Icon (ICLR) to $290 from $300 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and ...

Icon ( (ICLR)) has shared an update. On July 22, 2025, ICON plc’s Board of Directors authorized a new share repurchase program allowing the company to buy back up to $500 million of its outstanding ...

Baird analyst Eric Coldwell lowered the firm’s price target on Icon (ICLR) to $225 from $249 and keeps a Neutral rating on the shares. The firm is concerned about sector fundamental performance ...